Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Baptista
Trino
T
Martinez
Maritza
M
Lacruz
Anny
A
Arellano
Antonio
A
Mendoza
Soaira
S
Beaulieu
Serge
S
Hernández
Luis
L
Contreras
Quilianio
Q
Galeazzi
Tatiana
T
Vargas
Doritza
D
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001066:Appetite / Q000187:drug effects; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D005260:Female; D005476:Fluphenazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D000077152:Olanzapine; D012016:Reference Values; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents; D001786:Blood Glucose; D003692:Delayed-Action Preparations; D007328:Insulin; D001569:Benzodiazepines; C011825:fluphenazine depot; D018967:Risperidone; D000077152:Olanzapine; D005476:Fluphenazine